Malignant phenotype correlating with drug resistance in two human neuroblastoma cell lines
- 1 June 1994
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 19 (2) , 123-129
- https://doi.org/10.1007/bf01306453
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Effect of a Membrane-Active Agent on Uptake of Adriamycin in Lewis Lung Carcinoma Cells Derived from ‘Primary’ and ‘Metastatic’ GrowthsChemotherapy, 1992
- HT1080/DR4: A P-Glycoprotein-Negative Human Fibrosarcoma Cell Line Exhibiting Resistance to Topoisomerase II-Reactive Drugs Despite the Presence of a Drug-Sensitive Topoisomerase IIJNCI Journal of the National Cancer Institute, 1990
- Mechanism of multidrug resistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988
- Amplification and Expression of Genes Associated with Multidrug Resistance in Mammalian CellsScience, 1986
- Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell linesNature, 1985
- Comparison of stage IV and IV‐S neuroblastoma in the first year of lifeMedical and Pediatric Oncology, 1985
- Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell LinesScience, 1983
- Stage IVS neuroblastomaJournal of Pediatric Surgery, 1978
- Neuroblastoma: Review of the literature and an examination of factors contributing to its enigmatic characterCancer Treatment Reviews, 1976